Niu Li-Na, Wang Jun-Xia, Li Xia, Xu Yong-Jun, Qiu Li-Rong, Guo Sheng, Zhang Li-Zhen, Shang Yun
Department of Gynecology, Yuncheng Central Hospital, Yuncheng, China.
Department of General Family medicine, Yuncheng Central Hospital, Yuncheng, China.
Front Surg. 2022 May 16;9:877857. doi: 10.3389/fsurg.2022.877857. eCollection 2022.
Clinically, malignant gynecological tumors found by chance during the diagnosis and treatment of pelvic organ prolapse (POP) are rare, and they are usually missed, leading to delayed diagnosis and treatment. The initial treatment of these tumors cannot be standardized, and, as a single surgical intervention may not be able to treat both the tumor and prolapse, secondary surgery is usually needed, affecting the quality of life of patients.
The present study retrospectively analyzed the data of three patients who were diagnosed with malignant gynecological tumors during the diagnosis and treatment of POP. These patients were among 215 patients with POP treated in Yuncheng Central Hospital of Shanxi Province between January 2011 and May 2020. The case characteristics, surgical interventions, postoperative treatments, and follow-ups were summarized, and the characteristics of diagnosis and treatment were analyzed in the context of relevant literature.
As long as clinicians operate in strict accordance with the standards of diagnosis and treatment, obtain a complete medical history, undertake a physical examination, and remain diligent in auxiliary examinations, following existing clinical methods and diagnosis and treatment processes, patients with POP complicated with malignant gynecological tumors can be clearly diagnosed before and during surgery. In this way, initial treatment can be standardized, and surgical methods can be selected that address both the tumor and prolapse, thereby avoiding secondary surgery and improving the patient's quality of life.
临床上,在盆腔器官脱垂(POP)诊治过程中偶然发现的恶性妇科肿瘤较为罕见,通常易被漏诊,导致诊断和治疗延误。这些肿瘤的初始治疗无法标准化,而且由于单一手术干预可能无法同时治疗肿瘤和脱垂,通常需要二次手术,影响患者生活质量。
本研究回顾性分析了3例在POP诊治过程中被诊断为恶性妇科肿瘤患者的数据。这些患者来自2011年1月至2020年5月在山西省运城市中心医院接受治疗的215例POP患者。总结了病例特征、手术干预、术后治疗及随访情况,并结合相关文献分析了诊治特点。
只要临床医生严格按照诊治标准操作,获取完整病史,进行体格检查,并勤于辅助检查,遵循现有的临床方法和诊治流程,POP合并恶性妇科肿瘤的患者在手术前及手术中就能得到明确诊断。这样一来,初始治疗就能标准化,可选择既能治疗肿瘤又能解决脱垂问题的手术方法,从而避免二次手术,提高患者生活质量。